News, Policy & Media

24May

Government response to report on Brexit and medicines, medical devices and substances of human origin

Command paper responding to the Health and Social Care Committee's report 'Brexit: medicines, medical devices and substances of human origin'.

Published 23 May 2018
From:
Department of Health and Social Care, Intellectual Property Office, Medicines and Healthcare products Regulatory Agency, Office for Life Sciences, and Department for Exiting the European Union
Documents

Brexit: medicines, medical devices and substances of human origin – government response to the Health and Social Care Committee's 4th report of session 2017 to 2019
 

Details
This command paper sets out the government’s response to the Health and Social Care Committee’s report following their inquiry into Brexit: medicines, medical devices and substances of human origin.

The committee published their report on 21 March 2018.

This response was prepared by the Department of Health and Social Care, in collaboration with other government departments and agencies including:

the Medicines and Healthcare products Regulatory Agency
the Office for Life Sciences
the Intellectual Property Office
the Department for Exiting the European Union
Published 23 May 2018

Related

Business Secretary Kwasi Kwarteng has announced his preferred selection for the chair of UK Research...

Read More >

The Government is to work towards the reduction of health inequalities and disparities through the o...

Read More >

NICE has released a strategy and future vision document for the period 2021 to 2026 which is designe...

Read More >

From 1 January 2021 the Medicines and Healthcare products Regulatory Agency (MHRA) will take on the ...

Read More >

The US Department of Health and Human Services (HHS) has released a call for submissions of point-of...

Read More >

The United Kingdom has shared some objectives for the COP26 event in November with Central American ...

Read More >